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1. Introduction 
It is now well established that most, or all, of the 
protein inhibitors of trypsin contain a lyeptide bond 
which is susceptible to proteolytic attack by this en- 
zyme [ 1-3].  The resultant modified inhibitor, which 
now contains a split peptide bond, can still combine 
with trypsin, although usually at a reduced rate. Re- 
moval of the new COOH-terminal group by treatment 
with carboxypeptidase B, or substitution of the new 
a-amino group results in a total loss of activity [ 1 ], 
suggesting that the susceptible peptide bond is direct- 
ly involved in the formation of the stable complex 
[11. 
As would be expected from the known specificity 
of trypsin, the susceptible bonds which have been 
identified fall into two classes according to whether 
the COOH-terminal group is lysine or arginine. Lima 
bean inhibitor (LBI) belongs to the class of lysine in- 
hibitors, and the critical peptide bond has been iden- 
tified as Lys-Ser [4]. The proteolysis reversible 
and proceeds only to an equilibrium mixture in which 
native and modified inhibitor coexist [ 1 ]. The posi- 
tion of equilibrium depends upon external conditions 
and the nature of the inhibitor. 
Rapid dissociation of the complex formed with 
trypsin by either native or modified inhibitor invari- 
ably results in liberation of the native inhibitor with 
the critical peptide bond intact [ 1,3]. This may be 
interpreted to indicate that either the intact peptide 
bond is present in the stable complex or else that the 
dissociation is subject o kinetic control, with the 
rate of dissociation i to the native form being very 
much faster than that of the competing dissociation 
to yield the modified form. 
From the results ummarized above it has been 
concluded that the susceptible peptide bond is direct- 
ly involved in interaction with the catalytic site of 
trypsin and that the same stable complex is attained 
with both native and modified inhibitor [ 1,5]. It has 
been inferred further that the normal course of pro- 
teolysis of a peptide bond is in this case perturbed so 
that the enzyrne-substrate complex is stabilized to an 
abnormal degree. 
An important remaining question is whether the 
critical peptide bond is intact or split in the stable 
complex. This is directly related to the problem of 
the mode of stabilization of the complex. If the bond 
is split then it is reasonable to postulate that the com- 
plex is stabilized by formation of an acyl bond be- 
tween the new a-carboxyl group and the serine of 
the active site [ 1,2]. If, however, the peptide bond 
can be shown to be intact, then this model must 
clearly be discarded. The plausible alternatives in- 
clude the 'tetrahedral' complex, which has been'pro- 
posed as an intermediate in the enzyme-catalyzed hy-
drolysis of peptides [6]. 
Evidence bearing directly on this question is 
scanty. The observation that any substitution of the 
new a-amino group of modified soya bean inhibitor 
totally eliminates activity is of course consistent with 
the tetrahedral model, but might also merely reflect 
a steric blockage of formation of the acyl bond [7]. 
It has recently been reported that guanidination of 
LBI fails to remove inhibitor activity and, in fact, in- 
creases the rate of combination [8]. This treatment 
converts lysine to homoarginine [9]. Since LBI be- 
longs to the lysine class of trypsin inhibitors, it is 
probable that the critical Lys-Ser peptide bond of 
this inhibitor is thereby converted to a Homoarg-Ser 
bond. 
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Characteristics of modified and guanidinated LBI. 
Preparation 
Fraction of Fraction of 
Fraction lysine group serine groups 
modified guanidinated intact 
LBI-G 0 0.95 1.00 +- 0.05 
LBI-T 0.75 0 1.00 -+ 0.05 
LBI-T-G 0.75 0.95 1.00 -+ 0.05 
noted, although the cited rates of hydrolysis are rela- 
tiVely slow [13]. 
If the susceptible peptide bond of LBI, when con- 
verted to the Homoarg-X form, is indeed refractory 
to the action of  trypsin, then it is of course unlikely 
that the critical bond is split in the stable complex. 
Moreover, if LBI were first converted to the trypsin- 
modified form and then guanidinated it would be un- 
likely that trypsin could catalyze the reformation of  
the peptide bond. 
In view of  the interest of these points with respect 
to the general problem of the interaction of trypsin 
with its protein inhibitors, the consequences of the 
guanidination of native and modified LBI have been 
reinvestigated. 
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Fig. 1. Relative activity of trypsin (4.3 X 10 -5 mg/ml) in: 
0.1 M Tris and 0.1 M CaCI2, pH 8.0, at 25°C as a function of 
the weight ratio of added LBI. The trypsin contains 34% inac- 
tive material. The equivalence point occurs at a weight ratio 
of 0.21: (o) native LBI; (o) modified LBI (LBI-T); 
(zx) gtaanidinated LBI (LBI-G); (o) modified and then guani- 
dinated LBI (LBI-T-G). Inset: time dependence of trypsin 
activity for 4.3 X 10 -s mg/ml trypsin under the above condi- 
tions in the presence of 3.8 X 10 -~ mg/ml modified inhibitor. 
The existing evidence appears to indicate that, in 
the majority of cases, peptide bonds of the 
Homoarg-X class are resistant to the action of trypsin 
[ 10-12].  However, certain exceptions have been 
2. Materials 
Unfractionated LBI was purchased from the 
Worthington Biochemical Corporation. This consists 
of a mixture of the four principal variants plus one or 
more minor components of higher molecular weight. 
The latter were removed by fractionation on a 
40 × 1.5 cm Sephadex G-100 column eluted with 0.3 
M ammonium acetate, pH 7.0. The low molecular 
weight components appeared as a single effluent peak 
accounting for over 90% of the sample. The corre- 
sponding fractions were pooled and lyophilized. 
LBI variants I - IV  were isolated by DEAE chroma- 
tography, according to the procedure of Jones et al. 
[ 14]. In addition, a purified sample of component I 
was generously provided by Dr. L. Stevens. Carboxy- 
peptidase B and toluene sulfonyl arginine methyl ester 
(TAME) were obtained from Sigma. Methyl isourea 
bisulfate was purchased from Aldrich. The other re- 
agents used were reagent grade. Glass-redistilled water 
was used for the preparation of all solutions. 
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Fig. 2. Time dependence of hydrolysis of 0.001 M TAME in 
0.1 M Tris and 0.1 M CaC12, pH 8.0, at 25°C, by trypsin 
(6.4 X 10 -s mg/ml) in the presence of 2.0 mg/ml LBI. The or- 
dinate is the increase in absorbance at 247 nm: (~) no LBI; 
(o) native LBI; (o) guanidinated LBI (LBI-G). 
Carboxypeptidase B digestion of the trypsin-modified 
form was carried out in 0.1 M Tris, pH 8.0, at a car- 
boxypeptidase level of 1 mg/ml for 24 hr at 37°C. 
Amino acid analyses were carried out with a 
Beckman amino acid analyzer made available through 
the courtesy of Dr. Enrico Bucci. Protein hydrolysates 
for amino acid analysis was prepared by heating at 
105°C with 6 M HC1 in a sealed and evacuated glass 
tube. 
Assays for trypsin activity were made using a spec- 
trophotometric technique. Twenty microliter aliquots 
of solution were added to 2.0 ml of 0.001 M TAME 
in 0.1 M Tris, 0.1 M CaC12, pH 8.0 at 25°C, and 
mixed. The increase with time of absorbance at 247 
nm was monitored using a Gilford spectrophotometer. 
Prior to assay, trypsin and inhibitor were mixed in 
varying weight ratios in 0.1 M Tris and 0.1 M CaC12, 
pH 8.0, at 25°C. The concentration of trypsin was 
normally 0.05 mg/ml. Unless otherwise indicated, the 
mixture was allowed to stand for 15 rain prior to as- 
say. 
Disc acrylamide gel electrophoresis was carried out 
at pH 8.7 using the Bio-Rad apparatus, usually with 
7.5% polyacrylamide asthe main gel. The gels were 
stained with Coomassie blue. The stained gels were 




Guanidination of LBI was carried out by the pro- 
cedure of Hughes et al. [9]. A 1M solution of methyl 
isourea bisulfate was neutralized by the addition of 
solid barium hydroxide and the barium sulfate precipi- 
tate removed by centrifugation. Guanidination of a 1% 
LBI solution was carried out in 0.5 M methyl isourea, 
pH 10.6, for 48 hr at 3°C. After completion of the re- 
action the protein was separated from excess reagent 
by passage through a Sephadex G-25 column, eluting 
with 0.3 M NH4OAc, pH 7.0. The fractions containing 
protein were pooled and lyophilized. 
The trypsin-modified form of LBI was prepared by 
incubation of a 1 mg/ml solution in 0.1 M KC1 at pH 
3.15 with 0.02 mg/ml trypsin for 72 hr at 25°C. 
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The majority of the experiments reported here 
were made with unfractionated LBI, which had been 
freed from high molecular weight contaminants by 
gel filtration. This appears to be justified in the pres- 
ent case in view of the close similarity of the four 
variants in molecular size and amino acid composition, 
the identity of their susceptible peptide bonds, and 
the essential equivalence of the kinetics and equilibria 
of their interaction with trypsin [4, 8, 14]. 
In conformity with earlier studies [1,4, 8], the 
combination of native LBI with trypsin was found to 
be nearly stoichiometric atpH 8 when correction was 
made for the fraction of inactive trypsin (fig. 1). 
The modified form was produced by prolonged in- 
cubation with trypsin at pH 3.15 and 25°C [8]. The 
degree of conversion was assessed by treatment with 
carboxypeptidase B at pH 8 (see Methods) according 
to the procedure suggested by Krahn and Stevens [8]. 











Fig. 3. (a) Scan of disc gel electrophoresis pattern of LBI-I. 
The rate of combination of the modified inhibitor 
with trypsin is much slower than that of the native 
form (fig. 1), in conformity with the results of paral- 
lel studies upon LBI and other inhibitors [1, 3, 4]. 
However, at equilibrium the degree of inhibition pro- 
duced by a given level of modified inhibitor is the 





















Fig. 3. (b) LBI- I  after incubation with trypsin (2% of its 
mass) for 24hr atpH 3.15 in 0.1M KClat 25°C. 
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Fig. 3. (c) Guanidinated LBI-I. 
same as for the native (fig. 1). For the modified inhib- 
itor shown in fig. 1, the degree of conversion indi- 
cated by carboxypeptidase B treatment is 75% (table 
1). While the degree of conversion is significantly less 
than that reported by Krahn and Stevens [8], the 
majority of the inhibitor is present as the modified 
form. 
Guanidination of LBI resulted in 95% conversion 
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Fig. 3. (d) Guanidinated LBI-I  after incubation with trypsin 
under above conditions for 72 hr. 
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Fig. 3. (e) LBI-IV. 
indicates that less than one unreacted lysine remains 
per molecule. 
The guanidinated inhibitor shows an activity simi- 
lar to that of the native if initial rates of hydrolysis 
are measured (fig. 1). However, the apparent degree 
of inhibition does not attain completion, even at large 
inhibitor:trypsin ratios. This appears to be a conse- 
quence of a greatly enhanced rate of dissociation of 
the trypsin-inhibitor complex in the presence of 
0.001 M TAME, so that the observed rate increases 
markedly with time (fig. 2). The dissociation with 
time also occurs for the native inhibitor, but at a 
much slower rate (fig. 2). Thus the apparent residual 
tryptic activity observed at high inhibitor levels prob- 
ably arises from the finite degree of dissociation 
which has occurred in the presence of TAME during 
the interval (30-60  sec) before data can be recorded. 
If the modified inhibitor was then guanidinated, 
quite different behavior was observed (fig. 1). In this 
p 
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Fig. 3. (g) Guanidinated LBI-IV after incubation with tryp- 
sin under above conditions for 72 hr. 
case activity was reduced by 80% (table 1), becoming 
essentially equivalent to that of the modified, carboxy. 
peptidase-treated inhibitor. The degree of inhibition 
was not increased by allowing the trypsin-inhibitor 
mixture to incubate for periods up to 3 hr. It thus 
appears that conversion of the new C-terminal lysine 
to homoarginine in the modified inhibitor is sufficient 
to block combination with trypsin entirely or to slow 
the process ufficiently so that it does not occur to a 
significant extent over this time interval. 
The reaction with methyl isourea has been re- 
ported to be entirely specific for the e-amino groups 
of lysine [9, 15, 16]. In particular, it has been re- 
ported that a-amino groups do not react [ 15, 16]. 
This was verified in the present case by amino acid 
analysis of the modified guanidinated inhibitor. No 
loss of serine was observed (table 1), indicating that 
no a-amino substitution occurred. 
There remains the question of whether the guani- 
dinated inhibitor is indeed resistant to the action of 
trypsin. Guanidination of purified variant IV resulted 
in the appearance of a second component on disc gel 
electrophoresis, presumably reflecting the fact that 
conversion was not 100% (fig. 3). Incubation of the 
guanidinated inhibitor with 2% of its mass of trypsin 
for 72 hr at pH 3.15 did not alter the appearance of 
the pattern significantly and, in particular, did not 
I I0  
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cause the appearance of a new component of higher 
mobility, as would result from the splitting of a pep- 
tide bond. In contrast, treatment of the native form 
of an LBI variant with trypsin under the same condi- 
tions resulted in substantial conversion to the modi- 
fied form in a somewhat shorter period. 
It thus appears that splitting of  the susceptible pep- 
tide bond either does not occur for the guanidinated 
inhibitor under these conditions, or else proceeds at 
a rate which is much slower than that for the native 
inhibitor. 
The finding that guanidination of  modified LBI 
abolished activity, while guanidination of the native 
form did not, is readily explained if the critical pep- 
tide bond is intact in the stable complex. This would 
be the case for a complex of  the tetrahedral type. It 
can be reconciled with the model in which the bond 
is split in the complex only with the aid of  special as- 




The findings cited above have provided strong indi- 
cation that conversion of the critical Lys-Ser peptide 
bond of LBI to Homoarg-Ser does not block the in- 
teraction with trypsin, although the rate of dissocia- 
tion of  the complex is considerably increased. This is 
the case despite the fact that efforts to detect proteol- 
ysis of guanidinated LBI by trypsin have thus far 
yielded only negative results. 
Again it must be stressed that the statement, hat 
proteolysis was not observed, is operationally based 
and may reflect nothing more than a pronounced e- 
pression of the rate of  hydrolysis, as compared with 
that of native LBI under the same conditions. An alter- 
native explanation might be that the equilibria are 
displaced as a consequence of guanidination so as to 
favor to an overwhelming degree the intact peptide 
bond. This however seems omewhat unlikely in view 
of the chemical similarity of  homoarginine and the 
protonated form of lysine. 
In any event it is clear that the occurrence of a 
split peptide bond in the trypsin complex of guani- 
dinated LBI must be regarded with some degree of 
doubt. 
The observation that guanidination of modified 
LBI blocks its activity may be interpreted to mean 
that either no complex with trypsin is formed, or else 
that the rate of contbination is too slow to be mea- 
sured. Since no depression of the rate of association 
with trypsin occurs for the guanidinated form of na- 
tive LBI [8], the latter explanation is somewhat less 
likely. 
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